<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00887003</url>
  </required_header>
  <id_info>
    <org_study_id>04-392</org_study_id>
    <nct_id>NCT00887003</nct_id>
  </id_info>
  <brief_title>Epidural Study of Patients With Chronic Lower Back Pain</brief_title>
  <official_title>Effects of Volume and Dose of Local Anaesthetic Solution in Epidural Steroidal Injections for Patients With Chronic Lower Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine 4 different epidural dosing regimes of local
      anaesthetic solution in a series of 3 epidural injections over a period of 12 months to
      determine the optimum dose of anaesthetic solution for pain relief and to determine the
      nature of any adverse events by measuring anxiety and depression, functionality and any side
      effects of the medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the optimum dose of local anesthetic and the optimum volume of injected solution
      when used in an epidural steroid injection being given for pain relief to patients with
      chronic lower back pain, using pain scores as an assessment tool.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The volume and dose of local anesthetic injected epidurally, in combination with the steroid, will be measured against the duration and degree of pain relief.</measure>
    <time_frame>Pain scores will be measured at 6 time intervals throughout the study period, prior to 1st injection, 30 minutes post 1st injection, prior to 2nd injection and 3rd injections and at 3 and 6 month post the three month injection.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcomes will be scores on the Oswestry low back pain disability scale and the Hospital anxiety and depression scale correlated with treatment outcomes and adverse events.</measure>
    <time_frame>Oswestry scores and HADS scores will be calculated at 5 time periods throughout the study period, prior to 1st, 2nd, and 3rd injections and at 3 and 6 month post the three month injection.</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">252</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>LV/LD 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Volume, Low Dose (5cc, 5mg plain Bupivacaine) + 80mg Depo-Medrol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LV/HD 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Volume, High Dose (5cc, 10mg plain Bupivacaine) + 80mg Depo-Medrol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HV/LD 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Volume, Low Dose (10cc, 5mg plain Bupivacaine) + 80mg Depo-Medrol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HV/HD 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Volume, High Dose (10cc, 10mg plain Bupivacaine) + 80mg Depo-Medrol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Low Volume, Low Dose (5cc, 5mg plain Bupivacaine)</description>
    <arm_group_label>LV/LD 1</arm_group_label>
    <other_name>steroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Low Volume, High Dose (5cc, 10mg plain Bupivacaine)</description>
    <arm_group_label>LV/HD 2</arm_group_label>
    <other_name>steroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>High Volume, Low Dose (10cc, 5mg plain Bupivacaine)</description>
    <arm_group_label>HV/LD 3</arm_group_label>
    <other_name>steroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>High Volume, High Dose (10cc, 10mg plain Bupivacaine)</description>
    <arm_group_label>HV/HD 4</arm_group_label>
    <other_name>steroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Depo-Medrol</intervention_name>
    <description>80mg Depo-Medrol</description>
    <arm_group_label>LV/LD 1</arm_group_label>
    <arm_group_label>LV/HD 2</arm_group_label>
    <arm_group_label>HV/LD 3</arm_group_label>
    <arm_group_label>HV/HD 4</arm_group_label>
    <other_name>methylprednisolone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 years old

          -  lower back pains &gt; 6 months

          -  no lumbar epidural in past 6 months

          -  no previous back surgery

          -  written informed consent to participate in study

        Exclusion Criteria:

          -  acute lower back pain

          -  pregnancy

          -  significant psychiatric disease

          -  local or systemic infection

          -  coagulopathy/anticoagulant therapy

          -  bleeding diathesis

          -  presently enrolled in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian Mulcaster, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamilton Health Sciences Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2009</study_first_submitted>
  <study_first_submitted_qc>April 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2009</study_first_posted>
  <last_update_submitted>February 7, 2012</last_update_submitted>
  <last_update_submitted_qc>February 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidural</keyword>
  <keyword>volume</keyword>
  <keyword>dose</keyword>
  <keyword>pain relief</keyword>
  <keyword>steroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

